Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases

Surgery (United States)

Volumn 155, Issue 2, 2014, Pages 245-254

  Reissfelder, Christoph ^a,b   Brand, Karsten ^a   Sobiegalla, Julia ^a   Rahbari, Nuh N ^a   Bork, Ulrich ^a,b   Schirmacher, Peter ^a   Büchler, Markus W ^a   Weitz, Jürgen ^a,b   Koch, Moritz ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; COLORECTAL LIVER METASTASIS; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; LIVER INJURY; LIVER INJURY RISK SCORE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; STEATOSIS; VERY ELDERLY; ADJUVANT THERAPY; COLORECTAL NEOPLASMS; DRUG-INDUCED LIVER INJURY; FOLLOW UP; GERMANY; LIVER NEOPLASMS; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SECONDARY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DRUG-INDUCED LIVER INJURY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT;

EID: 84892593223     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.07.022     Document Type: Article

References (31)

1. G. Bengtsson, G. Carlsson, L. Hafstrom, and P.E. Jonsson Natural history of patients with treated liver metastases from colorectal cancer Am J Surg 141 1981 586 589
2. L. Staib, K.H. Link, A. Blatz, and H.G. Beger Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients-monoinstitutional experience World J Surg 26 2002 59 66
3. J. Weitz, M. Koch, J. Debus, T. Hohler, P.R. Galle, and M.W. Büchler Colorectal cancer Lancet 365 2005 153 165
4. M.A. Choti, J.V. Sitzmann, M.F. Tiburi, W. Sumetchotimetha, R. Rangsin, and R.D. Schulick et al. Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 2002 759 766
5. C. Reissfelder, N.N. Rahbari, M. Koch, A. Ulrich, I. Pfeilschifter, and A. Waltert et al. Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases Ann Surg Oncol 16 2009 3279 3288
6. B. Nordlinger, and S. Benoist Benefits and risks of neoadjuvant therapy for liver metastases J Clin Oncol 24 2006 4954 4955
7. A.A. Parikh, B. Gentner, T.T. Wu, S.A. Curley, L.M. Ellis, and J.N. Vauthey Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy J Gastrointest Surg 7 2003 1082 1088
8. V.P. Khatri, N.J. Petrelli, and J. Belghiti Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 23 2005 8490 8499
9. G.D. Leonard, B. Brenner, and N.E. Kemeny Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma J Clin Oncol 23 2005 2038 2048
10. E.K. Abdalla, and J.N. Vauthey Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful? Dig Surg 25 2008 421 429
11. T. Aloia, M. Sebagh, M. Plasse, V. Karam, F. Levi, and S. Giacchetti et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 2006 4983 4990
12. M. Karoui, C. Penna, M. Amin-Hashem, E. Mitry, S. Benoist, and B. Franc et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 2006 1 7
13. J.N. Vauthey, T.M. Pawlik, D. Ribero, T.T. Wu, D. Zorzi, and P.M. Hoff et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2006 2065 2072
14. T.M. Pawlik, K. Olino, A.L. Gleisner, M. Torbenson, R. Schulick, and M.A. Choti Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome J Gastrointest Surg 11 2007 860 868
15. T. Andre, C. Louvet, F. Maindrault-Goebel, C. Couteau, M. Mabro, and J.P. Lotz et al. CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR Eur J Cancer 35 1999 1343 1347
16. T. Andre, C. Boni, L. Mounedji-Boudiaf, M. Navarro, J. Tabernero, and T. Hickish et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2004 2343 2351
17. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
18. S.M. Strasberg, J. Belghiti, P.A. Clavien, E. Gadzijev, O.J. Garden, and W.Y. Lau et al. The Brisbane 2000 terminology of liver anatomy and resections HPB 2 2000 333 339
19. M. Koch, O.J. Garden, R. Padbury, N.N. Rahbari, R. Adam, and L. Capussotti et al. Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery Surgery 2011
20. N.N. Rahbari, O.J. Garden, R. Padbury, M. Brooke-Smith, M. Crawford, and R. Adam et al. Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS) Surgery 149 2011 713 724
21. F.G. Fernandez, J. Ritter, J.W. Goodwin, D.C. Linehan, W.G. Hawkins, and S.M. Strasberg Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases J Am Coll Surg 200 2005 845 853
22. L. Rubbia-Brandt, V. Audard, P. Sartoretti, A.D. Roth, C. Brezault, and M. Le Charpentier et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 2004 460 466
23. H. Nakano, E. Oussoultzoglou, E. Rosso, S. Casnedi, M.P. Chenard-Neu, and P. Dufour et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 2008 118 124
24. C. Reissfelder, N.N. Rahbari, M. Koch, B. Kofler, N. Sutedja, and H. Elbers et al. Postoperative course and clinical significance of biochemical blood tests following hepatic resection Br J Surg 98 2011 836 844
25. N.N. Rahbari, C. Reissfelder, M. Koch, H. Elbers, F. Striebel, and M.W. Buchler et al. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients Ann Surg Oncol 18 2011 3640 3649
26. K.E. Behrns, G.G. Tsiotos, N.F. DeSouza, M.K. Krishna, J. Ludwig, and D.M. Nagorney Hepatic steatosis as a potential risk factor for major hepatic resection J Gastrointest Surg 2 1998 292 298
27. D.A. Kooby, Y. Fong, A. Suriawinata, M. Gonen, P.J. Allen, and D.S. Klimstra et al. Impact of steatosis on perioperative outcome following hepatic resection J Gastrointest Surg 7 2003 1034 1044
28. D.A. Wicherts, R.J. de Haas, M. Sebagh, C.E. Saenz, D.L. Gorden, and F. Levi et al. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases Br J Surg 2010
29. L.M. Ellis, S.A. Curley, and A. Grothey Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab J Clin Oncol 23 2005 4853 4855
30. S.B. Kesmodel, L.M. Ellis, E. Lin, G.J. Chang, E.K. Abdalla, and S. Kopetz et al. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases J Clin Oncol 26 2008 5254 5260
31. F.A. Scappaticci, L. Fehrenbacher, T. Cartwright, J.D. Hainsworth, W. Heim, and J. Berlin et al. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab J Surg Oncol 91 2005 173 180